Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells.

Koppenhafer SL, Goss KL, Terry WW, Gordon DJ.

Mol Cancer Ther. 2018 Dec;17(12):2676-2688. doi: 10.1158/1535-7163.MCT-18-0260. Epub 2018 Oct 3.

PMID:
30282812
2.

Performance and predictors of recruitment success in National Heart, Lung, and Blood Institute's cardiovascular clinical trials.

Pemberton VL, Evans F, Gulin J, Rosenberg E, Addou E, Burns KM, Gordon DJ, Pearson GD, Kaltman JR.

Clin Trials. 2018 Oct;15(5):444-451. doi: 10.1177/1740774518792271. Epub 2018 Aug 7.

PMID:
30084662
3.

SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit In Vitro and In Vivo Efficacy.

Naumann JA, Widen JC, Jonart LA, Ebadi M, Tang J, Gordon DJ, Harki DA, Gordon PM.

Bioconjug Chem. 2018 Apr 18;29(4):1111-1118. doi: 10.1021/acs.bioconjchem.7b00774. Epub 2018 Feb 19.

PMID:
29412642
4.

Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine.

Goss KL, Koppenhafer SL, Harmoney KM, Terry WW, Gordon DJ.

Oncotarget. 2017 Jun 28;8(50):87016-87032. doi: 10.18632/oncotarget.18776. eCollection 2017 Oct 20.

5.

Development of Secondary Acute Myeloid Leukemia in a Pediatric Patient Concurrently Receiving Primary Therapy for Ewing Sarcoma.

McNew BR, Darbro BW, Ma D, Gordon DJ.

J Pediatr Hematol Oncol. 2017 Oct;39(7):e370-e372. doi: 10.1097/MPH.0000000000000924.

6.

Data monitoring committees: Promoting best practices to address emerging challenges.

Fleming TR, DeMets DL, Roe MT, Wittes J, Calis KA, Vora AN, Meisel A, Bain RP, Konstam MA, Pencina MJ, Gordon DJ, Mahaffey KW, Hennekens CH, Neaton JD, Pearson GD, Andersson TL, Pfeffer MA, Ellenberg SS.

Clin Trials. 2017 Apr;14(2):115-123. doi: 10.1177/1740774516688915. Epub 2017 Feb 1.

7.

Rejoinder.

Fleming TR, DeMets DL, Roe MT, Wittes J, Calis KA, Vora AN, Meisel A, Bain RP, Konstam MA, Pencina MJ, Gordon DJ, Mahaffey KW, Hennekens CH, Neaton JD, Pearson GD, Andersson TL, Pfeffer MA, Ellenberg SS.

Clin Trials. 2017 Apr;14(2):126-127. doi: 10.1177/1740774516688917. Epub 2017 Jan 31. No abstract available.

8.

Drug conjugated nanoparticles activated by cancer cell specific mRNA.

Gossai NP, Naumann JA, Li NS, Zamora EA, Gordon DJ, Piccirilli JA, Gordon PM.

Oncotarget. 2016 Jun 21;7(25):38243-38256. doi: 10.18632/oncotarget.9430.

9.

Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.

Goss KL, Gordon DJ.

Oncotarget. 2016 Sep 27;7(39):63003-63019. doi: 10.18632/oncotarget.11416.

10.

Modeling the initiation of Ewing sarcoma tumorigenesis in differentiating human embryonic stem cells.

Gordon DJ, Motwani M, Pellman D.

Oncogene. 2016 Jun 16;35(24):3092-102. doi: 10.1038/onc.2015.368. Epub 2015 Oct 12.

11.

Cognitive bias, hand preference and welfare of common marmosets.

Gordon DJ, Rogers LJ.

Behav Brain Res. 2015;287:100-8. doi: 10.1016/j.bbr.2015.03.037. Epub 2015 Mar 24.

PMID:
25813746
12.

Aurea mediocritas: the importance of a balanced genome.

Varetti G, Pellman D, Gordon DJ.

Cold Spring Harb Perspect Biol. 2014 Sep 18;6(11):a015842. doi: 10.1101/cshperspect.a015842. Review.

13.

Publication of trials funded by the National Heart, Lung, and Blood Institute.

Gordon DJ, Lauer MS.

N Engl J Med. 2014 Feb 20;370(8):782. doi: 10.1056/NEJMc1315653. No abstract available.

PMID:
24552337
14.

Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN).

Hare JM, Bolli R, Cooke JP, Gordon DJ, Henry TD, Perin EC, March KL, Murphy MP, Pepine CJ, Simari RD, Skarlatos SI, Traverse JH, Willerson JT, Szady AD, Taylor DA, Vojvodic RW, Yang PC, Moyé LA; Cardiovascular Cell Therapy Research Network.

Circulation. 2013 Apr 16;127(15):1630-5. doi: 10.1161/CIRCULATIONAHA.112.000779. No abstract available.

15.

Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.

Traverse JH, Henry TD, Pepine CJ, Willerson JT, Zhao DX, Ellis SG, Forder JR, Anderson RD, Hatzopoulos AK, Penn MS, Perin EC, Chambers J, Baran KW, Raveendran G, Lambert C, Lerman A, Simon DI, Vaughan DE, Lai D, Gee AP, Taylor DA, Cogle CR, Thomas JD, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Kappenman C, Westbrook L, Piller LB, Simpson LM, Baraniuk S, Loghin C, Aguilar D, Richman S, Zierold C, Spoon DB, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN).

JAMA. 2012 Dec 12;308(22):2380-9. Erratum in: JAMA. 2013 Jan 23;309(4):343. Erratum in: JAMA. 2015 Jul 7;314(1):86.

16.

The outcome at 15 years of endoscopic anterior cruciate ligament reconstruction using hamstring tendon autograft for 'isolated' anterior cruciate ligament rupture.

Bourke HE, Gordon DJ, Salmon LJ, Waller A, Linklater J, Pinczewski LA.

J Bone Joint Surg Br. 2012 May;94(5):630-7. doi: 10.1302/0301-620X.94B5.28675.

PMID:
22529082
17.

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.

Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN).

JAMA. 2012 Apr 25;307(16):1717-26. doi: 10.1001/jama.2012.418. Epub 2012 Mar 24. Erratum in: JAMA. 2015 Jul 7;314(1):86.

18.

Causes and consequences of aneuploidy in cancer.

Gordon DJ, Resio B, Pellman D.

Nat Rev Genet. 2012 Jan 24;13(3):189-203. doi: 10.1038/nrg3123. Review.

PMID:
22269907
19.

Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.

Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Forder JR, Byrne BJ, Hatzopoulos AK, Penn MS, Perin EC, Baran KW, Chambers J, Lambert C, Raveendran G, Simon DI, Vaughan DE, Simpson LM, Gee AP, Taylor DA, Cogle CR, Thomas JD, Silva GV, Jorgenson BC, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Smith DX, Baraniuk S, Piller LB, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD; Cardiovascular Cell Therapy ResearchNetwork.

JAMA. 2011 Nov 16;306(19):2110-9. doi: 10.1001/jama.2011.1670. Epub 2011 Nov 14.

20.

Differences in social and vocal behavior between left- and right-handed common marmosets (Callithrix jacchus).

Gordon DJ, Rogers LJ.

J Comp Psychol. 2010 Nov;124(4):402-11. doi: 10.1037/a0019736.

PMID:
20853949
21.

LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.

Traverse JH, Henry TD, Vaughan DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Simpson LM, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, Taylor DA, Cogle CR, Baraniuk S, Olson RE, Jorgenson BC, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moyè LA, Simari RD; Cardiovascular Cell Therapy Research Network.

Tex Heart Inst J. 2010;37(4):412-20.

22.

Intraosseous line placement for antidote injection by first responders and receivers wearing personal protective equipment.

Borron SW, Arias JC, Bauer CR, Philbeck T, Hass P, Lawson W, Montez D, Fernández M, Jung I, Gordon DJ.

Am J Emerg Med. 2011 May;29(4):373-81. doi: 10.1016/j.ajem.2009.10.009. Epub 2010 Apr 2.

PMID:
20825804
23.

Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design.

Willerson JT, Perin EC, Ellis SG, Pepine CJ, Henry TD, Zhao DX, Lai D, Penn MS, Byrne BJ, Silva G, Gee A, Traverse JH, Hatzopoulos AK, Forder JR, Martin D, Kronenberg M, Taylor DA, Cogle CR, Baraniuk S, Westbrook L, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moyé LA, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN).

Am Heart J. 2010 Aug;160(2):215-23. doi: 10.1016/j.ahj.2010.03.029.

24.

Modification of titanium alloy surfaces for percutaneous implants by covalently attaching laminin.

Gordon DJ, Bhagawati DD, Pendegrass CJ, Middleton CA, Blunn GW.

J Biomed Mater Res A. 2010 Aug;94(2):586-93. doi: 10.1002/jbm.a.32735.

PMID:
20198691
25.

Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: the antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT-LLT).

Margolis KL, Dunn K, Simpson LM, Ford CE, Williamson JD, Gordon DJ, Einhorn PT, Probstfield JL; ALLHAT Collaborative Research Group.

Am Heart J. 2009 Dec;158(6):948-55. doi: 10.1016/j.ahj.2009.10.001.

26.

A pediatric case series of acute hemolysis after administration of intravenous immunoglobulin.

Gordon DJ, Sloan SR, de Jong JL.

Am J Hematol. 2009 Nov;84(11):771-2. doi: 10.1002/ajh.21544. No abstract available.

27.

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.

Traverse JH, Henry TD, Vaughan DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Piller LB, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, Taylor DA, Cogle CR, Olson RE, Jorgenson BC, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moye' LA, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN).

Am Heart J. 2009 Sep;158(3):356-63. doi: 10.1016/j.ahj.2009.06.009. Epub 2009 Jul 23. Erratum in: Am Heart J. 2009 Dec;158(6):1045. Vaughn, Douglas E [corrected to Vaughan, Douglas E].

28.

Telemedicine and trauma referrals--a plastic surgery pilot project.

Diver AJ, Lewis H, Gordon DJ.

Ulster Med J. 2009 May;78(2):113-4.

29.

Management of emergency referrals to UK and Ireland plastic surgery units.

Diver AJ, Tohill MP, Sinclair SJ, Gordon DJ.

Int J Surg. 2009 Jun;7(3):276. doi: 10.1016/j.ijsu.2009.04.014. Epub 2009 May 7. No abstract available.

30.

When should data and safety monitoring committees share interim results in cardiovascular trials?

Borer JS, Gordon DJ, Geller NL.

JAMA. 2008 Apr 9;299(14):1710-2. doi: 10.1001/jama.299.14.1710. No abstract available.

PMID:
18398083
31.

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Fernando Costa.

Crit Pathw Cardiol. 2005 Dec;4(4):198-203. No abstract available.

PMID:
18340209
32.

Stories behind the numbers. I0 experiences in providers' own words.

Potyka JS, Gordon DJ.

JEMS. 2007 Oct;32(10):S30-1. No abstract available.

PMID:
17982794
33.

Similarities and differences in design considerations for cell therapy and pharmacologic cardiovascular clinical trials.

Lewis RM, Gordon DJ, Poole-Wilson PA, Borer JS, Zannad F.

Cardiology. 2008;110(2):73-80. Epub 2007 Oct 31. Review.

PMID:
17975310
34.

Elastic head dressing for scalp skin grafts.

Diver AJ, Rashid A, Gordon DJ.

Ann Plast Surg. 2007 Feb;58(2):230-1. No abstract available.

PMID:
17245161
35.

Peptide-based inhibitors of amyloid assembly.

Sciarretta KL, Gordon DJ, Meredith SC.

Methods Enzymol. 2006;413:273-312. Review.

PMID:
17046402
36.

Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids.

Sciarretta KL, Boire A, Gordon DJ, Meredith SC.

Biochemistry. 2006 Aug 8;45(31):9485-95.

PMID:
16878983
37.

Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary.

American Heart Association; National Heart, Lung, and Blood Institue, Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F.

Cardiol Rev. 2005 Nov-Dec;13(6):322-7. No abstract available.

PMID:
16708441
38.

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F.

Curr Opin Cardiol. 2006 Jan;21(1):1-6. Review. No abstract available.

PMID:
16355022
39.

Trends in serum lipids and lipoproteins of adults, 1960-2002.

Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, Grundy SM, Johnson CL.

JAMA. 2005 Oct 12;294(14):1773-81.

PMID:
16219880
40.

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute.

Circulation. 2005 Oct 25;112(17):2735-52. Epub 2005 Sep 12. Review. No abstract available. Erratum in: Circulation. 2005 Oct 25;112(17):e297. Circulation. 2005 Oct 25;112(17):e298.

PMID:
16157765
41.

Abeta40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid.

Sciarretta KL, Gordon DJ, Petkova AT, Tycko R, Meredith SC.

Biochemistry. 2005 Apr 26;44(16):6003-14.

PMID:
15835889
42.
43.

Male breast cancer in World War II aviation: a case report and review.

Gordon DJ, Chin KH, Budny PG, Taylor AR.

Breast. 2003 Apr;12(2):156-7. Review.

PMID:
14659347
44.
45.

Invasive front grading: reliability and usefulness in the management of oral squamous cell carcinoma.

Sawair FA, Irwin CR, Gordon DJ, Leonard AG, Stephenson M, Napier SS.

J Oral Pathol Med. 2003 Jan;32(1):1-9.

PMID:
12558952
47.

Women's angiographic vitamin and estrogen trial: design and methods.

Hsia J, Alderman EL, Verter JI, Rogers WJ, Thompson P, Howard BV, Cobb FR, Ouyang P, Tardif JC, Higginson L, Bittner V, Barofsky I, Steffes M, Gordon DJ, Proschan M, Younes N, Waters D.

Control Clin Trials. 2002 Dec;23(6):708-27.

PMID:
12505248
48.

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.

Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, Ouyang P, Thompson P, Tardif JC, Higginson L, Bittner V, Steffes M, Gordon DJ, Proschan M, Younes N, Verter JI.

JAMA. 2002 Nov 20;288(19):2432-40.

PMID:
12435256
49.
50.

Supplemental Content

Loading ...
Support Center